Virtu Financial LLC Invests $1.50 Million in Medpace Holdings, Inc. (NASDAQ:MEDP)

Virtu Financial LLC bought a new stake in Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 4,502 shares of the company's stock, valued at approximately $1,503,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of MEDP. Stone House Investment Management LLC acquired a new stake in shares of Medpace during the 3rd quarter valued at $33,000. Ashton Thomas Securities LLC acquired a new stake in shares of Medpace during the third quarter valued at about $37,000. DT Investment Partners LLC acquired a new stake in shares of Medpace during the second quarter valued at about $41,000. Capital Performance Advisors LLP bought a new stake in shares of Medpace during the third quarter worth about $46,000. Finally, Ashton Thomas Private Wealth LLC acquired a new position in shares of Medpace in the second quarter valued at approximately $52,000. Institutional investors own 77.98% of the company's stock.

Medpace Stock Down 0.4 %

MEDP traded down $1.50 during trading on Friday, hitting $345.93. The company's stock had a trading volume of 275,170 shares, compared to its average volume of 282,165. The firm has a market capitalization of $10.75 billion, a P/E ratio of 30.22, a PEG ratio of 1.89 and a beta of 1.37. Medpace Holdings, Inc. has a twelve month low of $277.72 and a twelve month high of $459.77. The stock's fifty day moving average price is $339.14 and its 200-day moving average price is $368.27.

Medpace (NASDAQ:MEDP - Get Free Report) last released its earnings results on Monday, October 21st. The company reported $3.01 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.77 by $0.24. Medpace had a net margin of 17.66% and a return on equity of 50.87%. The company had revenue of $533.32 million for the quarter, compared to the consensus estimate of $540.99 million. During the same quarter in the previous year, the company earned $2.22 EPS. Medpace's quarterly revenue was up 8.3% compared to the same quarter last year. Equities research analysts expect that Medpace Holdings, Inc. will post 11.93 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms recently commented on MEDP. StockNews.com downgraded shares of Medpace from a "buy" rating to a "hold" rating in a research report on Friday, September 27th. Jefferies Financial Group cut shares of Medpace from a "buy" rating to a "hold" rating and reduced their price objective for the stock from $415.00 to $345.00 in a research note on Wednesday, September 25th. Baird R W downgraded Medpace from a "strong-buy" rating to a "hold" rating in a report on Wednesday, October 23rd. TD Cowen cut their target price on Medpace from $413.00 to $372.00 and set a "buy" rating on the stock in a report on Wednesday, October 23rd. Finally, Truist Financial decreased their price target on Medpace from $415.00 to $397.00 and set a "hold" rating for the company in a research note on Monday, October 14th. Seven analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $380.56.

Medpace Company Profile

Medpace Holdings, Inc provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services.